BioCentury
ARTICLE | Company News

Le Groupe Pharmaceutique Boivin, Lucane Pharma sales and marketing update

December 16, 2013 8:00 AM UTC

Lucane granted Le Group Pharmaceutique's Medunik Canada subsidiary exclusive rights to commercialize Lucane's pheburane in Canada to treat urea cycle disorders. The formulation of sodium 4-phenylbutyr...